Stay updated on Repotrectinib in Rearranged Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Repotrectinib in Rearranged Solid Tumors Clinical Trial page.

Latest updates to the Repotrectinib in Rearranged Solid Tumors Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedRevision v3.5.0 has been added to the history, and Revision v3.4.3 has been removed.SummaryDifference0.0%

- Check26 days agoChange DetectedAdded revision v3.4.3 and removed revision v3.4.2 from the history list.SummaryDifference0.0%

- Check55 days agoChange DetectedThe history shows a new Revision: v3.4.2 added and the prior government funding notice/banner removed. These changes affect only site-wide notices and do not modify the study data, eligibility, or results.SummaryDifference0.3%

- Check62 days agoChange DetectedAdded a government funding lapse notice with status guidance and links to cc.nih.gov and opm.gov. Updated the page revision to v3.4.1.SummaryDifference0.3%

- Check69 days agoChange DetectedUI improvements to the record history page include a glossary display option, color-coded change indicators, and an updated revision tag (v3.4.0), with minor capitalization adjustments for FEAR Act text.SummaryDifference0.3%

- Check83 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed from the history.SummaryDifference0.0%

Stay in the know with updates to Repotrectinib in Rearranged Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Repotrectinib in Rearranged Solid Tumors Clinical Trial page.